BridgeMD
New treatment option for Stroke (CVA) or TIA
Official title NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
ClinicalTrials.gov ID: NCT07500116
What this study is testing
- What it's testing
- In this project, we aim to validate a Home Hospitalization plan for patients with TIA or minor stroke. Our hypothesis is that our Multimodal Home Hospitalization program (NORAHOME) for patients with TIA and minor stroke is safe, reduces the complications associated with conventional hospitalization, and is more efficient than Standard Clinical Practice.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients presenting to the Emergency Department with symptoms of TIA (complete recovery of neurological deficits within \<24 hours) or minor stroke...
- Age \>18 years.
- Availability of a smartphone for the patient or caregiver.
- Family support and/or formal caregiver.
- Clinical stability during the last 12 hours in the Emergency Department.
You likely can't join if
- Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion and/or arterial revascularization treatments.
- Patients with pre-existing neurological or psychiatric conditions that may interfere with or complicate follow-up and evaluations.
- Clinical (terminal condition) or social (language barrier) impossibility to complete follow-up assessments.
See the full eligibility criteria
- Patients presenting to the Emergency Department with symptoms of TIA (complete recovery of neurological deficits within \<24 hours) or minor stroke (NIHSS ≤ 5)
- Age \>18 years.
- Availability of a smartphone for the patient or caregiver.
- Family support and/or formal caregiver.
- Clinical stability during the last 12 hours in the Emergency Department.
- Signed informed consent by the patient and/or family member or legal representative.
- Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion and/or arterial revascularization treatments.
- Patients with pre-existing neurological or psychiatric conditions that may interfere with or complicate follow-up and evaluations.
- Clinical (terminal condition) or social (language barrier) impossibility to complete follow-up assessments.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.